Progress in allogeneic hematopoietic stem cell transplantation in treatment of hematological malignancies / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 65-67,82, 2017.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-605848
Biblioteca responsável:
WPRO
ABSTRACT
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a curable method for hematological malignancies.Nearly all transplant candidates have donor with the successful application of haploidentical SCT.This article summarized some reports on donor selection,prophylaxis and treatment of graft-versus-host disease,and graft failure in the 58th American Society of Hematology Annual Meeting to present the progress of allo-HSCT in treating hematological malignancies.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2017
Tipo de documento:
Artigo